An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers

Movement Disorders

Volumn 26, Issue 5, 2011, Pages 877-884

  Vaccarino, Anthony L ^a   Anderson, Karen ^b   Borowsky, Beth ^c   Duff, Kevin ^d   Giuliano, Joseph ^c   Guttman, Mark ^e   Ho, Aileen K ^f   Orth, Michael ^g   Paulsen, Jane S ^h   Sills, Terrence ^a   van Kammen, Daniel P ^c   Evans, Kenneth R ^a  

^a OCBN   (Canada)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c CHDI MANAGEMENT CHDI FOUNDATION   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e Centre for Movement Disorders   (Canada)

^f UNIVERSITY OF READING   (United Kingdom)

^g UNIVERSITY OF ULM   (Germany)

^h UNIVERSITY OF IOWA   (United States)

Author keywords

Huntington disease; Item response theory; UHDRS

Indexed keywords

ADULT; AGED; ARTICLE; BEHAVIOR; BODY POSTURE; BRADYKINESIA; CHOREA; DISEASE SEVERITY; DYSARTHRIA; FEMALE; GAIT; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; IRRITABILITY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MOTOR PERFORMANCE; MULTICENTER STUDY; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; RATING SCALE; UNIFIED HUNTINGTON DISEASE RATING SCALE; WALKING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BEHAVIORAL SYMPTOMS; DISABILITY EVALUATION; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; MOVEMENT DISORDERS; SEVERITY OF ILLNESS INDEX; TRINUCLEOTIDE REPEAT EXPANSION; YOUNG ADULT;

EID: 79955100548     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23574     Document Type: Article

References (35)

1. Bates GP, Murphy KP. In: Bates GP, Harper PS, Jones AL, eds. Huntington's Disease. Oxford, UK: Oxford University Press; 2002: 387-426.
2. Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Stout JC; Predict-HD Investigators of the Huntington Study Group. Psychiatric symptoms in Huntington's disease before diagnosis: the Predict-HD study. Biol Psychiatry. 2007; 62: 1341-1346.
3. Julien C, Thompson JC, Wild S, et al. Psychiatric disorders in preclinical Huntington's Disease. J Neurol Neurosurg Psychiatry. 2007; 78: 939-943.
4. Paulsen JS, Zhao H, Stout JC, et al. Clinical markers of early disease in persons near onset of Huntington's disease. Neurology. 2001; 57: 658-662.
5. Paulsen JS, Hayden M, Stout JC, et al. Preparing for preventive clinical trials: the PREDICT-HD Study. Arch Neurol. 2006; 63: 883-890.
6. Paulsen JS, Langbehn DR, Stout JC, et al. Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry. 2008; 79: 874-880.
7. Huntington Study Group. Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord. 1996; 11: 136-142.
8. Biglan KM, Ross CA, Langbehn DR, et al. Motor abnormalities in premanifest persons with Huntington's disease: the PREDICT-HD study. Mov Disord. 2009; 24: 1763-1772.
9. Jurgens CK, van de Wiel L, van Es AC, et al. Basal ganglia volume and clinical correlates in 'preclinical' Huntington's disease. J Neurol. 2008; 255: 1785-1791.
10. Rao AK, Louis ED, Marder KS. Clinical assessment of mobility and balance impairments in pre-symptomatic Huntington's disease. Gait Posture. 2009; 30: 391-393.
11. Evans K, Anderson K, Borowsky B, et al. The Functional Rating Scale Taskforce for Pre-Huntington's Disease: an empirically-driven initiative for new scale development. Neurotherapeutics. 2009; 6: 205.
12. Available at: http://www.euro-hd.net/html/registry.
13. Santor DA, Ramsay JO. Progress in the technology of measurement: Applications of Item Response models. Psychol Assess. 1998; 10: 345-59.
14. Evans KR, Sills TL, DeBrota DJ, Gelwicks S, Engelhardt N, Santor D. An item response analysis of the Hamilton Depression Rating Scale using shared data from two pharmaceutical companies. J Psychiatr Res. 2004; 38: 275-284.
15. Santor DA, Coyne JC. Examining symptom expression as a function of symptom severity: Item performance on the Hamilton Rating Scale for Depression. Psychol Assess. 2001; 13: 127-139.
16. Vaccarino AL, Evans KR, Sills TL, Kalali AH. Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression. Depression Anxiety. 2008; 25: 1006-1013.
17. Carmody TJ, Rush AJ, Bernstein I, et al. The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures. Eur Neuropsychopharmacol. 2006; 16: 601-611.
18. Kim Y, Pilkonis PA, Frank E, Thase ME, Reynolds CF. Differential functioning of the Beck depression inventory in late-life patients: use of item response theory. Psychol Aging. 2002; 17: 379-391.
19. Vaccarino AL, Evans KR, Sills TL, Kalali AH. Prevalence and association of somatic symptoms in patients with major depressive disorder. J Affect Dis. 2008; 110: 270-276.
20. Sills T, Wunderlich G, Pyke R, et al. The Sexual Interest and Desire Inventory-Female (SIDI-F): item response analyses of data from women diagnosed with hypoactive sexual desire disorder. J Sex Med. 2005; 2: 801-818.
21. Ramsay JO. TestGraf: a Program for the Graphical Analysis of Multiple Choice Test and Questionnaire Data. Montreal, Quebec, Canada: McGill University; 2000. Available at: ].
22. Ramsay JO. Kernel smoothing approaches to nonparametric item characteristic curve estimation. Psychometrika. 1991; 56: 611-630.
23. Paulsen JS. Early detection of Huntington's disease. Future Neurol. 2010; 5(1): 85-104.
24. Bechtel N, Jauffret C, Say M, et al. Force-transducer-based finger tapping as a potential biomarker in premanifest and symptomatic HD-cross-sectional results from the TRACK-HD Study. Clin Gen. 2009; 76(s1): 42.
25. Tabrizi SJ, Langbehn DR, Leavitt BR, et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol. 2009; 8: 791-801.
26. Meyer C, Ludolph AC, Landwehrmeyer B, Schwenke C, Doble A, Orth M. Modification of the Unified Huntington's Disease Rating Scale: Selection of items on the basis of the EHDI data. Clin Gen. 2009; 76(s1): 60.
27. Siesling S, Zwinderman AH, van Vugt JP, Kieburtz K, Roos RA. A shortened version of the motor section of the Unified Huntington's Disease Rating Scale. Mov Disord. 1997; 12: 229-234.
28. Louis ED, Anderson KE, Moskowitz C, Thorne DZ, Marder K. Dystonia-predominant adult-onset Huntington disease: association between motor phenotype and age of onset in adults. Arch Neurol. 2000; 57: 1326-1330.
29. Dewhurst K, Oliver JE, McKnight AL. Socio-psychiatric consequences of Huntington's disease. Br J Psychiatry. 1970; 116: 255-258.
30. Nehl C, Paulsen JS. Cognitive and psychiatric aspects of Huntington disease contribute to functional capacity. J Nerv Ment Dis. 2004; 192: 72-74.
31. Hoth KF, Paulsen JS, Moser DJ, et al. Patients with Huntington's disease have impaired awareness of cognitive, emotional, and functional abilities. J Clin Exp Neuropsychol. 2007; 29: 365-376.
32. Paulsen JS, Hoth KF, Nehl C, Stierman L. Critical periods of suicide risk in Huntington's disease. Am J Psychiatry. 2005; 162: 725-731.
33. Craufurd D, Thompson JC, Snowden JS. Behavioral changes in Huntington disease. Neuropsychiatry Neuropsychol Behav Neurol. 2001; 14: 219-226.
34. Hanson S, Davis M, Altevogt B. CNS Clinical Trials: Suicidality and Data Collection: Workshop Summary. Washington, DC: National Academies Press; 2010.
35. Bonelli RM, Hofmann P. A systematic review of the treatment studies in Huntington's disease since 1990. Expert Opin Pharmacother. 2007; 8: 141-153.